Home

itthon Correlate Lepődj meg a promising circulating marker for bone metastasis response Repülési csokor kiállítás

Novel approaches to target the microenvironment of bone metastasis | Nature  Reviews Clinical Oncology
Novel approaches to target the microenvironment of bone metastasis | Nature Reviews Clinical Oncology

Frontiers | Cross Talk Between Macrophages and Cancer Cells in the Bone  Metastatic Environment
Frontiers | Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment

Combinatorial targeting of cancer bone metastasis using mRNA engineered  stem cells - eBioMedicine
Combinatorial targeting of cancer bone metastasis using mRNA engineered stem cells - eBioMedicine

Modular Design of High-Brightness pH-Activatable Near-Infrared BODIPY  Probes for Noninvasive Fluorescence Detection of Deep-Seated Early Breast Cancer  Bone Metastasis: Remarkable Axial Substituent Effect on Performance | ACS  Central Science
Modular Design of High-Brightness pH-Activatable Near-Infrared BODIPY Probes for Noninvasive Fluorescence Detection of Deep-Seated Early Breast Cancer Bone Metastasis: Remarkable Axial Substituent Effect on Performance | ACS Central Science

Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better  Therapeutic Outcome: State of the Art and Future Perspectives | Journal of  Medicinal Chemistry
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives | Journal of Medicinal Chemistry

Bone metastasis: mechanisms, therapies, and biomarkers | Physiological  Reviews
Bone metastasis: mechanisms, therapies, and biomarkers | Physiological Reviews

Prostate-specific membrane antigen in circulating tumor cells is a new poor  prognostic marker for castration-resistant prostate cancer | PLOS ONE
Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer | PLOS ONE

Frontiers | Cell-Free DNA: Hope and Potential Application in Cancer
Frontiers | Cell-Free DNA: Hope and Potential Application in Cancer

GDF15 promotes prostate cancer bone metastasis and colonization through  osteoblastic CCL2 and RANKL activation | Bone Research
GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation | Bone Research

Cells | Free Full-Text | Breast Cancer with Bone Metastasis: Molecular  Insights and Clinical Management
Cells | Free Full-Text | Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management

Cancers | Free Full-Text | Radium-223 Treatment of Patients with Metastatic  Castration Resistant Prostate Cancer: Biomarkers for Stratification and  Response Evaluation
Cancers | Free Full-Text | Radium-223 Treatment of Patients with Metastatic Castration Resistant Prostate Cancer: Biomarkers for Stratification and Response Evaluation

Cancers | Free Full-Text | Hypoxia in Lung Cancer Management: A  Translational Approach
Cancers | Free Full-Text | Hypoxia in Lung Cancer Management: A Translational Approach

Evolving cancer–niche interactions and therapeutic targets during bone  metastasis | Nature Reviews Cancer
Evolving cancer–niche interactions and therapeutic targets during bone metastasis | Nature Reviews Cancer

Frontiers | Circulating Tumor Cells: A Promising Biomarker in the  Management of Nasopharyngeal Carcinoma
Frontiers | Circulating Tumor Cells: A Promising Biomarker in the Management of Nasopharyngeal Carcinoma

Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment |  Journal of Nuclear Medicine
Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment | Journal of Nuclear Medicine

RANKL: A promising circulating marker for bone metastasis response
RANKL: A promising circulating marker for bone metastasis response

IJMS | Free Full-Text | Understanding the Progression of Bone Metastases to  Identify Novel Therapeutic Targets
IJMS | Free Full-Text | Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets

Subtyping of metastatic breast cancer based on plasma circulating tumor DNA  alterations: An observational, multicentre platform study -  eClinicalMedicine
Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study - eClinicalMedicine

Better together: circulating tumor cell clustering in metastatic cancer:  Trends in Cancer
Better together: circulating tumor cell clustering in metastatic cancer: Trends in Cancer

Extracellular vesicles as a promising biomarker resource in liquid biopsy  for cancer
Extracellular vesicles as a promising biomarker resource in liquid biopsy for cancer

Updates on liquid biopsy: current trends and future perspectives for  clinical application in solid tumors
Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors

Frontiers | Current and Emerging Biomarkers Predicting Bone Metastasis  Development
Frontiers | Current and Emerging Biomarkers Predicting Bone Metastasis Development

Cancers | Free Full-Text | Circulating Tumor Cells from Enumeration to  Analysis: Current Challenges and Future Opportunities
Cancers | Free Full-Text | Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities

Frontiers | Predictive and Prognostic Biomarkers for Lung Cancer Bone  Metastasis and Their Therapeutic Value
Frontiers | Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value